Cargando…

How does IL-6 change after combined treatment in MDD patients? A systematic review

A growing amount of research suggests that inflammatory responses have a crucial role in the complex pathophysiology of Major Depressive Disorder (MDD), a disabling medical condition. The present review has two primary goals. Firstly, to highlight and summarize results from studies that investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Aurora Leontina, Manfredi, Lucia, Conversi, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822965/ https://www.ncbi.nlm.nih.gov/pubmed/36624849 http://dx.doi.org/10.1016/j.bbih.2022.100579

Ejemplares similares

The change of gut microbiota in MDD patients under SSRIs treatment
por: Shen, Yang, et al.
Publicado: (2021)

Why is Diagnosing MDD Challenging?
Publicado: (2016)

POSTPARTUM GAD IS A RISK FACTOR FOR POSTPARTUM MDD: THE COURSE AND LONGITUDINAL RELATIONSHIPS OF POSTPARTUM GAD AND MDD
por: Prenoveau, Jason, et al.
Publicado: (2013)

From MDD concepts to experiments and illustrations
por: Babau, Jean-Philippe, et al.
Publicado: (2006)

The neurocognitive profile of post‐traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
por: Koopowitz, Sheri‐Michelle, et al.
Publicado: (2021)

RPS6KA5 methylation predict response to 6-week treatment for adolescent MDD patients
por: Xu, Peiwei, et al.
Publicado: (2022)

REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats
por: Bifari, Francesco, et al.
Publicado: (2022)

A Systematic Review of Genetic Polymorphisms Associated with Binge Eating Disorder
por: Manfredi, Lucia, et al.
Publicado: (2021)

The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms
por: Liu, Penghong, et al.
Publicado: (2019)

Comparison of Electroencephalography (EEG) Coherence between Major Depressive Disorder (MDD) without Comorbidity and MDD Comorbid with Internet Gaming Disorder
por: Youh, Joohyung, et al.
Publicado: (2017)

A Systematic Review of Genetic Polymorphisms Associated with Bipolar Disorder Comorbid to Substance Abuse
por: de Marco, Adriano, et al.
Publicado: (2022)

MEASURING COGNITIVE FUNCTION IN MDD: EMERGING ASSESSMENT TOOLS
por: Russo, Manuela, et al.
Publicado: (2015)

The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia
por: Quek, Yue Feng, et al.
Publicado: (2021)

Pharmacogenomics of MDD as a Developing Field: Challenges and Opportunities
por: Baune, B.
Publicado: (2022)

S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): a clinician-oriented systematic review
por: Cuomo, Alessandro, et al.
Publicado: (2020)

Il mio allievo Carlo Rubbia
por: Conversi, M
Publicado: (1984)

PS185. Opposite 1-H MRS Cho changes in amygdala and DLPFC in responders after SSRI as monotherapy in MDD
por: Henigsberg, Neven, et al.
Publicado: (2016)

Patient attitudes toward and goals for MDD treatment: a survey study
por: McNaughton, Emily C, et al.
Publicado: (2019)

Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD
por: Li, Gaizhi, et al.
Publicado: (2018)

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study
por: Novick, Diego, et al.
Publicado: (2017)

Early improvement of painful symptoms in MDD: is there an association in achieving remission?
por: Bär, Karl-Jürgen
Publicado: (2007)

Relationship of Mean Platelet Volume To MDD: A Retrospective Study
Publicado: (2017)

PTSD and comorbid MDD is associated with activation of the right frontoparietal network
por: Koopowitz, Sheri-Michelle, et al.
Publicado: (2023)

Aberrant Resting-State Functional Connectivity in MDD and the Antidepressant Treatment Effect—A 6-Month Follow-Up Study
por: Li, Kangning, et al.
Publicado: (2023)

A survey of five antidepressant properties influencing clinician’s treatment choices in MDD
por: Papakostas, George I, et al.
Publicado: (2007)

Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Findings from real-world clinical practice on tDCS treatment of MDD
por: Panhelainen, A.
Publicado: (2023)

The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD)
por: Pieters, T., et al.
Publicado: (2022)

A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD)
por: Ng, Chong Guan, et al.
Publicado: (2023)

Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review
por: Salloum, Naji C., et al.
Publicado: (2020)

The process of major depressive disorder (MDD) in women referred to the health centers
por: Rahmati-Khameneh, Souraj, et al.
Publicado: (2011)

An Examination of Psychomotor Disturbance in Current and Remitted MDD: An RDoC Study
por: Shankman, Stewart A., et al.
Publicado: (2020)

The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
por: Papalexi, E., et al.
Publicado: (2021)

The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
por: Waters, Kristin
Publicado: (2022)

How does major abdominal surgery induce procalcitonin and IL-6 in the postoperative period?
por: Karpel, EK
Publicado: (2000)

The minimum detectable difference (MDD) and the interpretation of treatment-related effects of pesticides in experimental ecosystems
por: Brock, T. C. M., et al.
Publicado: (2014)

Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
por: Leutner, Michael, et al.
Publicado: (2021)

Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
por: Zelada, Mario Ignacio, et al.
Publicado: (2023)

Early Adverse Events, HPA Activity and Rostral Anterior Cingulate Volume in MDD
por: Treadway, Michael T., et al.
Publicado: (2009)

Reconfiguration of Cortical Networks in MDD Uncovered by Multiscale Community Detection with fMRI
por: He, Ye, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n5fmp44u96k3o3v2q6bv2bvk5g